These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21131762)

  • 1. Microspheres in cancer therapy.
    Rajput MS; Agrawal P
    Indian J Cancer; 2010; 47(4):458-68. PubMed ID: 21131762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeting technology utilizing magnetic microparticulate system for cancer therapy].
    Morimoto Y; Natsume H
    Nihon Rinsho; 1998 Mar; 56(3):649-56. PubMed ID: 9549351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal cancer therapy: exploiting tumor characteristics.
    Kaasgaard T; Andresen TL
    Expert Opin Drug Deliv; 2010 Feb; 7(2):225-43. PubMed ID: 20095944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles for drug delivery in cancer treatment.
    Haley B; Frenkel E
    Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of anticancer drugs.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN; Shen Q; Li SS
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle and targeted systems for cancer therapy.
    Brannon-Peppas L; Blanchette JO
    Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetically modulated therapeutic systems.
    Häfeli UO
    Int J Pharm; 2004 Jun; 277(1-2):19-24. PubMed ID: 15158965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.
    Wagner E; Kircheis R; Walker GF
    Biomed Pharmacother; 2004 Apr; 58(3):152-61. PubMed ID: 15082337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.
    Greish K
    Methods Mol Biol; 2010; 624():25-37. PubMed ID: 20217587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool.
    Kaneda Y
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1079-93. PubMed ID: 20716020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polyamine transport system as a target for anticancer drug development.
    Palmer AJ; Wallace HM
    Amino Acids; 2010 Feb; 38(2):415-22. PubMed ID: 19956998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic nanoparticles for cancer therapy.
    Bilensoy E
    Expert Opin Drug Deliv; 2010 Jul; 7(7):795-809. PubMed ID: 20446858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nanocarrier systems in cancer nanotherapy.
    Mozafari MR; Pardakhty A; Azarmi S; Jazayeri JA; Nokhodchi A; Omri A
    J Liposome Res; 2009; 19(4):310-21. PubMed ID: 19863166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.